Study Highlights Obesity Patients Who May Benefit Most from GLP-1 Treatments | Retatrutide News

The Mayo Clinic study identifies obesity patients who benefit most from GLP-1 treatments. This could optimize Retatrutide's use in personalized obesity ...
Clinical Trials · October 25, 2026